Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Somatostatin receptor type 1 (SSTR1) is a G protein-coupled receptor that mediates the biological effects of somatostatin. It inhibits the release of various hormones and secretory proteins and is involved in regulating endocrine, neuronal, and gastrointestinal functions. SSTR1 has been implicated as a potential tumor suppressor, with altered expression observed in certain cancers. Synthetic ligands targeting SSTR1 are being investigated for treating endocrine tumors.
Activation of inhibitory G proteins, decreased cyclic AMP levels, downstream inhibition or modulation of target cellular processes such as hormone secretion or cell proliferation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Somatostatin Receptor Type 1 (SSTR1).